Propionic Acid

Propionic Acid

SCHEMBL4159540

CCC(=O)O.O=c1[nH]c2cc(F)ccc2c2cc[nH]c12

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.43
KDM4E B2RXH2 4/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 3/20 0.42
HSD17B10 Q99714 3/20 0.42
GLA P06280 2/20 0.42
CYP3A4 P08684 2/20 0.42
LMNA P02545 2/20 0.42
CYP2D6 P10635 2/20 0.42
KMT2A Q03164 2/20 0.42
TP53 P04637 1/20 0.42
POLB P06746 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
DYRK1A Q13627 1/20 0.42
HASPIN Q8TF76 1/20 0.42
DYRK2 Q92630 1/20 0.42
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4160624 0.90 MPO (0.43) KDM4ECDK2CDC25ACDC25CCHEK1
Propionic Acid SCHEMBL4166119 0.85 PARP1 (0.49) PARP1KDM4EALDH1A1HPGDCYP3A4
Propionic Acid SCHEMBL4153202 0.82 ACHE (0.47) KDM4EALDH1A1HPGDHSD17B10CYP3A4
Propionic Acid SCHEMBL4171576 0.81 PIM1 (0.46) PARP1KDM4EALDH1A1HPGDHSD17B10
Propionic Acid SCHEMBL4162597 0.79 KDM4E (0.43) KDM4EALDH1A1HPGDHSD17B10KMT2A
Propionic Acid SCHEMBL4176382 0.78 GRIN1 (0.35) KDM4EALDH1A1HPGDHSD17B10GLA
Propionic Acid SCHEMBL4169911 0.77 GABRA1 (0.41) PARP1KDM4EALDH1A1HPGDHSD17B10
Propionic Acid SCHEMBL4155436 0.77 PIM3 (0.49) KDM4EALDH1A1HPGDLMNAKMT2A
Propionic Acid SCHEMBL4165125 0.77 PARP1 (0.47) PARP1KDM4EALDH1A1HPGDHSD17B10
Propionic Acid SCHEMBL4169905 0.76 KIF11 (0.45) PARP1KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 PARP1 628/4885KDM4E 1970/4885ALDH1A1 3830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.